R & D systems INC:1107462 - recombinant human ubiquitin rhodamine 110, CF, custom size
Ended Awarded
- Contract number
- HHSN31900003
- Awardee
-
Research And Diagnostic Systems, Inc. UEI WAYSQU5HJYT9 Part of Bio-Techne Corporation
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,251
Award facts
- Contract value 100% obligated
- $6,250.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55413, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN31900003?
HHSN31900003 was awarded to Research And Diagnostic Systems, Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on January 30, 2015.
How much is contract HHSN31900003 worth?
The government has obligated $6,251 on HHSN31900003.
Is contract HHSN31900003 an order under another contract?
Yes. HHSN31900003 is a BPA call under HHSN263199900050140B, a blanket purchase agreement.
Was contract HHSN31900003 competed?
The extent of competition for HHSN31900003 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award